Hillel P Cohen

8PUBLICATIONS
9CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyGene and molecular therapyOther literatures in English
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 17, 2025
Global Harmonization of Biosimilar Development by Overcoming Existing Differences in Regional Regulatory Requirements - Outcomes of a Descriptive Review.

Thomas M Kirchlechner, Hillel P Cohen

|Nov 15, 2024
Comparing anti-drug antibody signal-to-noise ratios to assess immunogenicity and interchangeability in adalimumab biosimilar studies.

Lena Lemke, Andrew Blauvelt, Ines Brückmann

|Mar 23, 2024
Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching.

Hillel P Cohen, Wolfram Bodenmueller

|Oct 30, 2023
Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch.

Sreedhar Sagi, Pradeep Anjaneya, Sameer Kalsekar

|Aug 05, 2023
Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer's Perspective.

Hillel P Cohen, Matthew Turner, Dorothy McCabe

|Jul 26, 2022
Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies.

Hillel P Cohen, Sohaib Hachaichi, Wolfram Bodenmueller

Pageof 2

Frequent Collaborators

1 joint publications

Tore K Kvien

1 joint publications

Andrew Blauvelt

1 joint publications

Matthew Turner

1 joint publications

Dorothy McCabe